TEM TOMOGRAPHY OF A DROSOPHILA ATP6 MUTATION
TEM TOMOGRAPHY OF A DROSOPHILA ATP6 MUTATION
批准号:
7598374
负责人:
Michael John Palladino
金额:
$0.46万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-02-01 至 2008-01-31
关键词:
AddressCatalysisComplementComputer Retrieval of Information on Scientific Projects DatabaseCouplesCrista ampullarisDiseaseDrosophila genusF1F0-ATP synthaseFrequenciesFundingGenesGenotypeGrantHumanImpairmentInheritedInstitutionIonsLongevityMembraneMitochondriaModelingMorphologyMutationNerve DegenerationOrthologous GeneOuter Mitochondrial MembranePeripheralProductionProtocols documentationRadialReportingResearchResearch PersonnelResolutionResourcesSourceSurfaceTechniquesTestingTubeTubular formationUnited States National Institutes of HealthVesicleabstractingaging braindensitymutantreconstructiontomography
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
ABSTRACT
Our studies of mutations that cause shortened lifespan and neurodegeneration have led us to identify a maternally inherited mutation in the mitochondrial gene ATP6 (ortholog of ATPa). This gene encodes the H+ channel component of the F1F0 ATP synthase, which couples ion gradient dissipation with ATP production via rotary catalysis. In humans, impairment of ATP6 generally manifests in diseases when the mutation is nearly homoplastic. For example, humans bearing the best-characterized mutation in the mitochondrial ATP6 gene (L156R) have MILS, NARP, or are normal depending upon the heteroplasmy of the mutation (>~85%, ~70-85% or <~70% mutant, respectively). In our mutant, ATP6[1] the mutation in nearly homoplastic (98¿4 % mutant). TEM analysis revealed aberrant cristae in mitochondria from ATP6[1] mutants (Figure 1). We have acquired the micrographs using stereological protocols and have discovered the density of mitochondria in ATP6[1] (31 ¿ 3 per 100mM2) does not appear to be significantly different than wild type (35 ¿ 2 per 100mM2, p=0.4). We would like to better understand this morphological aberration to complement our ongoing functional studies of these mitochondria. Specifically, is the internal mitochondiral membrane vesiciular (as it appears in 2D TEM) or is it tubular? Does the internal membrane remain separate from the outer mitochondrial membrane? TEM tomography with a 5nm resolution is extremely well-suited to directly address both of these questions, which have profound consequences on the function of mitochondria. The quality of our 2D TEM and the high frequency with which we see aberrant mitochondria in our mutants suggests the proposed project will not be overly burdensome and will yield instructive results.
Figure 1: TEM analysis of aged brains reveals aberrant mitochondrial morphology in ATP6[1] mutants (B). N > 3 each genotype. Quantification demonstrates a high frequency of abnormal mitochondria (>60% of total mitochondria, C). Comparison to wild type (* p<0.01, T-test).
In the previous reporting period, blocks from wild-type and ATP6 mutant were received. A double-tilt reconstruction made from each. Dr. Renken collected an additional single-tilt reconstruction from the mutant, using the Tecnai F20. Surface-rendered models, using both tracing and thresholding techniques, were made. In mitochondria from the mutant, there appears to be a radial progression from peripheral tubes to central vesicles.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Developing the first TPI Df therapeutics
-
批准号:10393677
-
项目类别:
-
资助金额:$54.32万
-
财政年份:2021
-
负责人:Michael John Palladino
-
依托单位:
Developing the first TPI Df therapeutics
-
批准号:10613470
-
项目类别:
-
资助金额:$53.85万
-
财政年份:2021
-
负责人:Michael John Palladino
-
依托单位:
Developing the first TPI Df therapeutics
-
批准号:10229007
-
项目类别:
-
资助金额:$54.35万
-
财政年份:2021
-
负责人:Michael John Palladino
-
依托单位:
Developing a murine TPI Df model
-
批准号:10294798
-
项目类别:
-
资助金额:$15.78万
-
财政年份:2021
-
负责人:Michael John Palladino
-
依托单位:
High-content screening for TPI Deficiency therapeutics
-
批准号:10662471
-
项目类别:
-
资助金额:$54.33万
-
财政年份:2021
-
负责人:Michael John Palladino
-
依托单位:
High-content screening for TPI Deficiency therapeutics
-
批准号:10312211
-
项目类别:
-
资助金额:$57.85万
-
财政年份:2021
-
负责人:Michael John Palladino
-
依托单位:
Genetic modulation of mitochondrial function
-
批准号:9542442
-
项目类别:
-
资助金额:$23.44万
-
财政年份:2018
-
负责人:Michael John Palladino
-
依托单位:
Pre-clinical studies of novel mitochondrial gene therapies
-
批准号:9036405
-
项目类别:
-
资助金额:$28.71万
-
财政年份:2015
-
负责人:Michael John Palladino
-
依托单位:
Determining the cellular and molecular basis of mitochondrial encephalomyopathy seizures
-
批准号:9150332
-
项目类别:
-
资助金额:$19.25万
-
财政年份:2015
-
负责人:Michael John Palladino
-
依托单位:
Pre-clinical studies of novel mitochondrial gene therapies
-
批准号:9411127
-
项目类别:
-
资助金额:$28.68万
-
财政年份:2015
-
负责人:Michael John Palladino
-
依托单位:
Pre-clinical studies of novel mitochondrial gene therapies
-
批准号:9212818
-
项目类别:
-
资助金额:$28.69万
-
财政年份:2015
-
负责人:Michael John Palladino
-
依托单位:
Mitochondrial RNA transport as a novel therapy
-
批准号:8412983
-
项目类别:
-
资助金额:$18.27万
-
财政年份:2012
-
负责人:Michael John Palladino
-
依托单位:
Protein quality control mechanisms of novel soluble substrates
-
批准号:8402430
-
项目类别:
-
资助金额:$29.36万
-
财政年份:2012
-
负责人:Michael John Palladino
-
依托单位:
Protein quality control mechanisms of novel soluble substrates
-
批准号:8646931
-
项目类别:
-
资助金额:$28.52万
-
财政年份:2012
-
负责人:Michael John Palladino
-
依托单位:
Protein quality control mechanisms of novel soluble substrates
-
批准号:8836557
-
项目类别:
-
资助金额:$28.69万
-
财政年份:2012
-
负责人:Michael John Palladino
-
依托单位:
Protein quality control mechanisms of novel soluble substrates
-
批准号:8518415
-
项目类别:
-
资助金额:$27.63万
-
财政年份:2012
-
负责人:Michael John Palladino
-
依托单位:
Mitochondrial RNA transport as a novel therapy
-
批准号:8271020
-
项目类别:
-
资助金额:$22.73万
-
财政年份:2012
-
负责人:Michael John Palladino
-
依托单位:
Mitochondrial Dysfunction and Progressive Encephalomyopathies
-
批准号:7927102
-
项目类别:
-
资助金额:$37.88万
-
财政年份:2009
-
负责人:Michael John Palladino
-
依托单位:
Mitochondrial Dysfunction and Progressive Encephalomyopathies
-
批准号:7686654
-
项目类别:
-
资助金额:$37.88万
-
财政年份:2009
-
负责人:Michael John Palladino
-
依托单位:
TEM TOMOGRAPHY OF A DROSOPHILA ATP6 MUTATION
-
批准号:7721714
-
项目类别:
-
资助金额:$1.11万
-
财政年份:2008
-
负责人:Michael John Palladino
-
依托单位:
国内基金
海外基金
不对称Tandem catalysis 合成手性仲醇
-
批准号:20643008
-
项目类别:专项基金项目
-
资助金额:8.0万元
-
批准年份:2006
-
负责人:孙伟
-
依托单位: